Stock Ticker

  • Loading stock data...

GlaxoSmithKline plc (ADR) (NYSE:GSK) Earns $500 Million Slap In China

Boston, MA 09/19/2014 (wallstreetpr) – GlaxoSmithKline plc (ADR) (NYSE:GSK) is set to pay for more than it allegedly illegally consumed in China. The $113 billion British pharmaceutical giant will have to part with nearly $500 million to settle claims of bribery that earned it about $150 million in revenue, BBC News reported in an article. […]

EBOLA Vaccine of GlaxoSmithKline plc (ADR) (NYSE:GSK) To Be Tasted Soon on Humans

Boston, MA 08/28/2014 (wallstreetpr) – EBOLA has created a huge buzz around the world in very limited time. Hundreds of people have died due to this deadly virus which has not any cure. Scientists from all around the world have been trying their best to find any vaccine for EBOLA virus for a long time […]

Buyers Line Up For InterMune Inc (NASDAQ:ITMN) As Shares Jump 14%

Boston, MA 08/14/2014 (wallstreetpr) –Shares of the lung drug developer, InterMune Inc (NASDAQ:ITMN), ended on a positive note on Wednesday, jumping 14.44% to $52.06. All that happened while potential buyers continued to circle the company with buyout agenda. People with insider knowledge have identified a number of European drug companies that include Sanofi and Roche […]

Ebola vaccine of GlaxoSmithKline plc (ADR) (NYSE:GSK) To Undergone Clinical Trial Soon

Boston, MA 08/11/2014 (wallstreetpr) – Ebola Virus has already caused thousands of deaths in all parts of the world, especially in Europe and African countries, but drug makers are yet to find out the vaccine. In amidst of deaths all around the world, reports about GlaxoSmithKline plc (ADR) (NYSE:GSK)‘s new vaccine for Ebola can be a […]

GlaxoSmithKline plc (ADR) (NYSE:GSK) Employees under Probe Over Bribery Allegations

Boston, MA 07/28/2014 (wallstreetpr) – GlaxoSmithKline plc (ADR) (NYSE:GSK) employees are reported to have been the subject of an investigation carried out by the FBI on bribery allegations made against the company on its operations in China and Syria. The Department of Justice (DOJ) has also carried out its own investigations on the company’s operation […]

Johnson & Johnson (NYSE:JNJ) Loses Money In China, Jumps Into Another Problem In Chicago

Boston, MA 06/06/2014 (wallstreetpr) – The year 2014 does not seem to be an easy one for the world’s biggest healthcare products maker Johnson & Johnson (NYSE:JNJ), at least going by the recent developments.  While the company’s ability to generate profits is hard to dismiss, JNJ is somewhat under siege and may end up losing its […]

Most Mentioned Stocks: Altria Group Inc (NYSE:MO), Health Care REIT, Inc. (NYSE:HCN), Pharmacyclics, Inc. (NASDAQ:PCYC)

Boston, MA 06/03/2014 (wallstreetpr) – Altria Group Inc (NYSE:MO) will pay a quarterly dividend of $0.48 per share on July 10, to shareholders who will have acquired its share by June 16. The newly declared quarterly dividend represents 4.73 percent on annualized basis.  The company has kept a good fight in the cigarette industry, and […]

Start Due Diligence Here: Strayer Education Inc (NASDAQ:STRA), American Caresource Holdings, Inc. (NASDAQ:ANCI), Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

Boston, MA 05/19/2014 (wallstreetpr) – After reporting 1Q2014 results that exceeded Wall Street estimates, Strayer Education Inc (NASDAQ:STRA) looks forward to undertaking more cost reduction efforts to support financial savings and maximize shareholder value. The company intends to save $50 million in operating expenses every year. The post-secondary education provider earned $1.40 per share in […]

Novartis AG (ADR) (NYSE:NVS) Settles Patent Litigation With the U.S. Subsidiary Of Sun Pharmaceutical

Boston, MA 05/15/2014 (wallstreetpr) – The Switzerland-based drug giant Novartis AG (ADR) (NYSE:NVS) has reached another milestone with the latest patent litigation settlement in the U.S.  The company reached a settlement with the U.S. subsidiary of Sun Pharmaceutical Industries.  The agreement touches on the development of a generic version of Gleevec, a patented prescription drug […]

GlaxoSmithKline plc (ADR) (NYSE:GSK) – Fails To Prove Its Strength In The 1Q2014

Boston, MA 05/07/2014 (wallstreetpr) – GlaxoSmithKline plc (ADR) (NYSE:GSK), the U.K. based biggest drug-maker expressed its happiness after the company remained as ‘interested observer’. The CEO, Andrew Witty, said that it was a joyous moment for the company, not to directly involve with the rivalry AstraZeneca Plc on the basis of the potential sale.  Critical […]

Novartis AG (ADR) (NYSE:NVS) Reverses Gear On Acquisition Deal

Boston, MA 05/05/2014 (wallstreetpr) – The Swiss-based Novartis AG (ADR) (NYSE:NVS) was due to acquire the ownership of Jerusalem-based Gamida Cell, a stem cell technology company. However, that transaction is off, according to the parent companies of Gamida. Novartis was planned to take over the full ownership of Gamida in a sale transaction valued at $600 […]

Merck & Co., Inc. (NYSE:MRK) In $14 Billion Asset Sale Talks With Bayer AG

Boston, MA 05/02/2014 (wallstreetpr) – Merck & Co., Inc. (NYSE:MRK) is reported to be in exclusive asset sale talks with the German pharmaceutical giant Bayer AG, according to the people with insider knowledge. Talks with Bayer for the sale of Merck’s over-the-counter business comes on the back of a withdrawal of one of the front bidders. […]

Who Wants To Buy Sanofi SA (ADR) (NYSE:SNY)’s Older Drugs Division?

Boston, MA 05/01/2014 (wallstreetpr) – Sanofi SA (ADR) (NYSE:SNY) is on the verge of selling its older drugs portfolio. The portfolio is reported to be made up of drugs targeted at the treatment of cardio-metabolic conditions and high blood pressure. The drug portfolio fetches about $3.7 billion in annual revenue, according to people with insider knowledge. […]

Sanofi SA (ADR) (NYSE:SNY) Prefers Small Deals Over Mega Acquisitions

Boston, MA 04/29/2014 (wallstreetpr) – On Tuesday, Sanofi SA (ADR) (NYSE:SNY)‘s Chief Executive Officer, Christopher Viehbacher, reiterated that the French drug maker will continue to concentrate on its targeted smaller acquisitions, even as the pharmaceutical sector is hitting several megadeals. Focus On Growth Areas The comment of Mr. Viehbacher comes at a time when a day […]

Pfizer Inc (NYSE:PFE) Among The Ten To Collaborate With The U.S. Government In Combating America’s Most Prevalent Diseases

Boston, MA 02/06/2014 (wallstreetpr) – Pfizer Inc (NYSE:PFE) is to work with the U.S. government to develop new treatments for some of the most prevalent diseases among Americans. In a $230 million project the government is trying to identify new cure for Alzheimer’s, diabetes, lupus and arthritis. In accordance with the practice of ‘groundbreaking’ at […]